Effects of Sleep Disturbance before Initiation of Epirubicin and Cyclophosphamide Combination Therapy on Chemotherapy-induced Nausea and Vomiting for Breast Cancer Patients-Reference-Cited by-同舟云学术

Effects of Sleep Disturbance before Initiation of Epirubicin and Cyclophosphamide Combination Therapy on Chemotherapy-induced Nausea and Vomiting for Breast Cancer Patients

Published:2023-03-10 Issue:3 Volume:49 Page:102-110
ISSN:1346-342X
Container-title:Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
language:en
Short-container-title:Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)

Author:

Inada Yusuke¹,Ariyama Tomohiro²,Kyotani Mitsutaka¹,Kurosu Tomohiro¹,Tateishi Tomoko¹,Okamoto Mariko³,Chishima Takashi⁴,Arioka Hitoshi⁵,Yamashita Atsushi¹

Affiliation:

1. Department of Pharmacy, Yokohama Rosai Hospital

2. Department of Clinical Pharmaceutics, Faculty of Pharmaceutical Sciences, Toho University

3. Department of Nursing, Yokohama Rosai Hospital

4. Department of Breast Surgery, Yokohama Rosai Hospital

5. Department of Medical Oncology, Yokohama Rosai Hospital

Publisher

Japanese Society of Pharmaceutical Health Care and Sciences

Link

https://www.jstage.jst.go.jp/article/jjphcs/49/3/49_102/_pdf

Reference24 articles.

1. 1）de Boer-Dennert M, de Wit R, Schmitz PI, Djontono J, v Beurden V, Stoter G, Verweij J, Patient perceptions of the side-effects of chemotherapy: the influence of 5HT₃ antagonists, Br J Cancer, 1997, 76, 1055-1061．

2. 2）Coates A, Abraham S, Kaye SB, Sowerbutts T, Frewin C, Fox RM, Tattersall MH, On the receiving end-patient perception of the side-effects of cancer chemotherapy, Eur J Cancer Clin Oncol, 1983, 19, 203-208．

3. 3）Hesketh PJ, Kris MG, Basch E, Bohlke K, Barbour SY, Clark-Snow RA, Danso MA, Dennis K, Dupuis LL, Dusetzina SB, Eng C, Feyer PC, Jordan K, Noonan K, Sparacio D, Lyman GH, Antiemetics: American Society of Clinical Oncology Focused Guideline Update, J Clin Oncol, 2020, 38, 2782-2797．

4. 4）Roila F, Molassiotis A, Herrstedt J, Aapro M, Gralla RJ, Bruera E, Clark-Snow RA, Dupuis LL, Einhorn LH, Feyer P, Hesketh PJ, Jordan K, Olver I, Rapoport BL, Roscoe J, Ruhlmann CH, Walsh D, Warr D, van der Wetering M; participants of the MASCC/ESMO Consensus Conference Copenhagen 2015, 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients, Ann Oncol, 2016, 27, 119-133．

5. 5）NCCN clinical practice guidelines in oncology Antiemetics Version 2, NCCN, org, 2022．